Studies evaluate levothyroxine’s impact on cardiovascular disease risk in midlife and older women and in adults with ...
Capital Market on MSN
Stock Alert: Zydus Lifesciences, Brigade Enterprises, Nibe, Medico Remedies, LTIMindtree
Zydus Lifesciences announced that it has received approval from Health Canada to market Liothyronine tablets, a therapeutic ...
Hypothyroidism was associated with an increased risk for small intestinal bacterial overgrowth across sexes, age groups, and BMI categories.
Zydus Lifesciences announced that it has received a Notice of Compliance (NOC) from Health Canada for its generic Liothyronine tablets in 5 mcg and 25 mcg strengths.
Zydus Lifesciences received regulatory approvals from Health Canada for generic Liothyronine tablets and from the USFDA for ...
Irish Examiner on MSN
Tired or thyroid? How to identify and deal with problems with 'the body's generator'
The thyroid can be overactive or underactive, leading to weight loss or gain. Around 10% of women believe they’ve experienced ...
SAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025 after ...
A new study from Boston University has found that surgery may be a better long-term treatment for people with hyperthyroidism ...
MedPage Today on MSN
Gene-Editing Therapy Promising for Rare Hereditary Disease
A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...
Health on MSN
What To Know About Polyphagia
Polyphagia is excessive hunger, often due to health issues like diabetes or hyperthyroidism. Managing polyphagia may involve ...
More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback